New findings on the action of hypericin in hypoxic cancer cells with a focus on the modulation of side population cells
The presence of key hypoxia regulators, namely, hypoxia-inducible factor (HIF)-1α or HIF-2α, in tumors is associated with poor patient prognosis. Hypoxia massively activates several genes, including the one encoding the BCRP transporter that proffers multidrug resistance to cancer cells through the...
Main Authors: | Viktória Buľková, Jana Vargová, Marián Babinčák, Rastislav Jendželovský, Zbyněk Zdráhal, Pavel Roudnický, Ján Košuth, Peter Fedoročko |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-07-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332223006194 |
Similar Items
-
Hypericin in the light and in the dark: Two sides of the same coin
by: Zuzana eJendzelovska, et al.
Published: (2016-05-01) -
Death Receptor 5 (TNFRSF10B) Is Upregulated and TRAIL Resistance Is Reversed in Hypoxia and Normoxia in Colorectal Cancer Cell Lines after Treatment with Skyrin, the Active Metabolite of <i>Hypericum</i> spp.
by: Marián Babinčák, et al.
Published: (2021-04-01) -
Photodynamic Therapy with Hypericin Improved by Targeting HSP90 Associated Proteins
by: Peter Ferenc, et al.
Published: (2011-11-01) -
Potentiality, Limitations, and Consequences of Different Experimental Models to Improve Photodynamic Therapy for Cancer Treatment in Relation to Antiangiogenic Mechanism
by: Martin Majerník, et al.
Published: (2020-07-01) -
The analysis of the kinetics of extraction of resinoids and hypericines from the amber, Hypericum perforatum L.
by: ANDRIJA A. SMELCEROVIC, et al.
Published: (2002-06-01)